General details Tax Identification Number (N.I.F): A-96184882 Company name: Laboratorio Reig Jofre SA Abbreviated name: Reig Jofre Sector: Pharma Legal Entity Identifier (LEI): 9598003MRMJHA81QJF20 Share capital Number of shares: 76,062,457 Par value: 0.50 euros/share Ordinary stock: 38,031,228.50 Euros Number of attributed voting rights: 76,062,457 Number of shares required for each voting right: 1 Stock market trading Share identification number (ISIN): ES0165359029 Incorporation to the interconnected trading system: 29/11/2002 Markets: Barcelona, Bilbao, Madrid and Valencia Trading ticker: RJF/AC Capital nominal R.V.: 128,306,356 Euros Trading type: Equities only
62.7% - Reig Jofre Investments SL 10.1% - Natra SA 5.5% - Onchena, SL 21.3% - Free float 0.4% - Treasury Stock
Shares split / reverse split
On September 22, 2015 the cancellation and consolidation of shares (reverse split) approved by the Ordinary and Extraordinary General Shareholders’ Meeting of Laboratorio Reig Jofre SA of June 11, 2015 was formalized with an exchange ratio of 20 existing shares for every new share.
Summary of the reverse split:.
Before the reverse split
Shares composing the share capital: 1,264,284,408
Par value: 0.10 euros/share
ISIN number: ES0165359011
After the reverse split
Shares composing the share capital: 63,214,220
Par value: 2.00 euros/share
ISIN number: ES0165359029
On December 31, 2018, the company owned 292,744 own shares, representing 0.3% of the share capital.
Shareholdings in listed companies
Reig Jofre currently holds no shareholding in any listed company.
Communication Policy to Shareholders